APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-animal Capsule

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-animal Capsule Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025197 pages

Choose your research edition.

Industry ResearchNon-animal Capsule Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-animal Capsule Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Non-animal Capsule Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-animal Capsule Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-animal Capsule Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Non-animal Capsule market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non-animal Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-animal Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-animal Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-animal Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-animal Capsule include Qingdao Capsule, Lonza (Capsugel), Shanxi GS Capsule, Sunil Healthcare, Suheung Capsule, SIRIO, Robinson Pharma, Qualicaps and Procaps Laboratorios, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-animal Capsule market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-animal Capsule and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-animal Capsule sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-animal Capsule market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-animal Capsule Segment by Company

Qingdao Capsule

Lonza (Capsugel)

Shanxi GS Capsule

Sunil Healthcare

Suheung Capsule

SIRIO

Robinson Pharma

Qualicaps

Procaps Laboratorios

Lefan Capsule

Eurocaps

Er-kang

Catalent

Captek

CapsCanada

Best Formulations

Bahrain Pharma

Aenova

ACG Associated Capsules

Non-animal Capsule Segment by Type

HPMC

Starch

Plant Polysaccharides

Others

Non-animal Capsule Segment by Application

Pharmaceutical

Health Supplements

Others

Non-animal Capsule Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-animal Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-animal Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-animal Capsule.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-animal Capsule market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-animal Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-animal Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non-animal Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non-animal Capsule Industry Trends Table 2. Non-animal Capsule Industry Drivers Table 3. Non-animal Capsule Industry Opportunities and Challenges Table 4. Non-animal Capsule Industry Restraints Table 5. Global Non-animal Capsule Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non-animal Capsule Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non-animal Capsule Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Non-animal Capsule Sales Market Share by Manufacturers Table 9. Global Non-animal Capsule Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Non-animal Capsule Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non-animal Capsule Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non-animal Capsule Manufacturers, Product Type & Application Table 13. Global Non-animal Capsule Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-animal Capsule by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of HPMC Table 17. Major Manufacturers of Starch Table 18. Major Manufacturers of Plant Polysaccharides Table 19. Major Manufacturers of Others Table 20. Global Non-animal Capsule Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Non-animal Capsule Sales by Type (2021-2026) & (W Units) Table 22. Global Non-animal Capsule Sales by Type (2027-2032) & (W Units) Table 23. Global Non-animal Capsule Sales Market Share by Type (2021-2026) Table 24. Global Non-animal Capsule Sales Market Share by Type (2027-2032) Table 25. Global Non-animal Capsule Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 26. Global Non-animal Capsule Revenue by Type (2021-2026) & (W Units) Table 27. Global Non-animal Capsule Revenue by Type (2027-2032) & (W Units) Table 28. Global Non-animal Capsule Revenue Market Share by Type (2021-2026) Table 29. Global Non-animal Capsule Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pharmaceutical Table 31. Major Manufacturers of Health Supplements Table 32. Major Manufacturers of Others Table 33. Global Non-animal Capsule Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Non-animal Capsule Sales by Application (2021-2026) & (W Units) Table 35. Global Non-animal Capsule Sales by Application (2027-2032) & (W Units) Table 36. Global Non-animal Capsule Sales Market Share by Application (2021-2026) Table 37. Global Non-animal Capsule Sales Market Share by Application (2027-2032) Table 38. Global Non-animal Capsule Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 39. Global Non-animal Capsule Revenue by Application (2021-2026) & (W Units) Table 40. Global Non-animal Capsule Revenue by Application (2027-2032) & (W Units) Table 41. Global Non-animal Capsule Revenue Market Share by Application (2021-2026) Table 42. Global Non-animal Capsule Revenue Market Share by Application (2027-2032) Table 43. Global Non-animal Capsule Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Non-animal Capsule Sales by Region (2021-2026) & (W Units) Table 45. Global Non-animal Capsule Sales Market Share by Region (2021-2026) Table 46. Global Non-animal Capsule Sales Forecasted by Region (2027-2032) & (W Units) Table 47. Global Non-animal Capsule Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Non-animal Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. North America Non-animal Capsule Sales by Country (2021-2026) & (W Units) Table 50. North America Non-animal Capsule Sales by Country (2027-2032) & (W Units) Table 51. Europe Non-animal Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Europe Non-animal Capsule Sales by Country (2021-2026) & (W Units) Table 53. Europe Non-animal Capsule Sales by Country (2027-2032) & (W Units) Table 54. Asia Pacific Non-animal Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Asia Pacific Non-animal Capsule Sales by Country (2021-2026) & (W Units) Table 56. Asia Pacific Non-animal Capsule Sales by Country (2027-2032) & (W Units) Table 57. South America, Middle East and Africa Non-animal Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. South America, Middle East and Africa Non-animal Capsule Sales by Country (2021-2026) & (W Units) Table 59. South America, Middle East and Africa Non-animal Capsule Sales by Country (2027-2032) & (W Units) Table 60. Global Non-animal Capsule Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Non-animal Capsule Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Non-animal Capsule Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Non-animal Capsule Revenue Market Share by Region (2021-2026) Table 64. Global Non-animal Capsule Revenue Market Share by Region (2027-2032) Table 65. Qingdao Capsule Company Information Table 66. Qingdao Capsule Business Overview Table 67. Qingdao Capsule Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Qingdao Capsule Non-animal Capsule Product Portfolio Table 69. Qingdao Capsule Recent Development Table 70. Lonza (Capsugel) Company Information Table 71. Lonza (Capsugel) Business Overview Table 72. Lonza (Capsugel) Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Lonza (Capsugel) Non-animal Capsule Product Portfolio Table 74. Lonza (Capsugel) Recent Development Table 75. Shanxi GS Capsule Company Information Table 76. Shanxi GS Capsule Business Overview Table 77. Shanxi GS Capsule Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Shanxi GS Capsule Non-animal Capsule Product Portfolio Table 79. Shanxi GS Capsule Recent Development Table 80. Sunil Healthcare Company Information Table 81. Sunil Healthcare Business Overview Table 82. Sunil Healthcare Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Sunil Healthcare Non-animal Capsule Product Portfolio Table 84. Sunil Healthcare Recent Development Table 85. Suheung Capsule Company Information Table 86. Suheung Capsule Business Overview Table 87. Suheung Capsule Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Suheung Capsule Non-animal Capsule Product Portfolio Table 89. Suheung Capsule Recent Development Table 90. SIRIO Company Information Table 91. SIRIO Business Overview Table 92. SIRIO Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. SIRIO Non-animal Capsule Product Portfolio Table 94. SIRIO Recent Development Table 95. Robinson Pharma Company Information Table 96. Robinson Pharma Business Overview Table 97. Robinson Pharma Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Robinson Pharma Non-animal Capsule Product Portfolio Table 99. Robinson Pharma Recent Development Table 100. Qualicaps Company Information Table 101. Qualicaps Business Overview Table 102. Qualicaps Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Qualicaps Non-animal Capsule Product Portfolio Table 104. Qualicaps Recent Development Table 105. Procaps Laboratorios Company Information Table 106. Procaps Laboratorios Business Overview Table 107. Procaps Laboratorios Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Procaps Laboratorios Non-animal Capsule Product Portfolio Table 109. Procaps Laboratorios Recent Development Table 110. Lefan Capsule Company Information Table 111. Lefan Capsule Business Overview Table 112. Lefan Capsule Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Lefan Capsule Non-animal Capsule Product Portfolio Table 114. Lefan Capsule Recent Development Table 115. Eurocaps Company Information Table 116. Eurocaps Business Overview Table 117. Eurocaps Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Eurocaps Non-animal Capsule Product Portfolio Table 119. Eurocaps Recent Development Table 120. Er-kang Company Information Table 121. Er-kang Business Overview Table 122. Er-kang Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Er-kang Non-animal Capsule Product Portfolio Table 124. Er-kang Recent Development Table 125. Catalent Company Information Table 126. Catalent Business Overview Table 127. Catalent Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Catalent Non-animal Capsule Product Portfolio Table 129. Catalent Recent Development Table 130. Captek Company Information Table 131. Captek Business Overview Table 132. Captek Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Captek Non-animal Capsule Product Portfolio Table 134. Captek Recent Development Table 135. CapsCanada Company Information Table 136. CapsCanada Business Overview Table 137. CapsCanada Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. CapsCanada Non-animal Capsule Product Portfolio Table 139. CapsCanada Recent Development Table 140. Best Formulations Company Information Table 141. Best Formulations Business Overview Table 142. Best Formulations Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Best Formulations Non-animal Capsule Product Portfolio Table 144. Best Formulations Recent Development Table 145. Bahrain Pharma Company Information Table 146. Bahrain Pharma Business Overview Table 147. Bahrain Pharma Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Bahrain Pharma Non-animal Capsule Product Portfolio Table 149. Bahrain Pharma Recent Development Table 150. Aenova Company Information Table 151. Aenova Business Overview Table 152. Aenova Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Aenova Non-animal Capsule Product Portfolio Table 154. Aenova Recent Development Table 155. ACG Associated Capsules Company Information Table 156. ACG Associated Capsules Business Overview Table 157. ACG Associated Capsules Non-animal Capsule Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. ACG Associated Capsules Non-animal Capsule Product Portfolio Table 159. ACG Associated Capsules Recent Development Table 160. Key Raw Materials Table 161. Raw Materials Key Suppliers Table 162. Non-animal Capsule Distributors List Table 163. Non-animal Capsule Customers List Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Non-animal Capsule Product Image Figure 2. Global Non-animal Capsule Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-animal Capsule Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-animal Capsule Sales (2021-2032) & (W Units) Figure 5. Global Non-animal Capsule Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Non-animal Capsule Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. HPMC Image Figure 9. Starch Image Figure 10. Plant Polysaccharides Image Figure 11. Others Image Figure 12. Global Non-animal Capsule Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Non-animal Capsule Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Non-animal Capsule Sales Market Share by Type (2021-2032) Figure 15. Global Non-animal Capsule Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Non-animal Capsule Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Non-animal Capsule Revenue Market Share by Type (2021-2032) Figure 18. Pharmaceutical Image Figure 19. Health Supplements Image Figure 20. Others Image Figure 21. Global Non-animal Capsule Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Non-animal Capsule Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Non-animal Capsule Sales Market Share by Application (2021-2032) Figure 24. Global Non-animal Capsule Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Non-animal Capsule Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Non-animal Capsule Revenue Market Share by Application (2021-2032) Figure 27. North America Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 28. North America Non-animal Capsule Sales Market Share by Country (2021-2032) Figure 29. U.S. Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Canada Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Mexico Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Non-animal Capsule Sales Market Share by Country (2021-2032) Figure 34. Germany Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 35. France Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 36. U.K. Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Italy Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Netherlands Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Non-animal Capsule Sales Market Share by Country (2021-2032) Figure 41. China Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Japan Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 43. South Korea Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Southeast Asia Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 45. India Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Australia Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Non-animal Capsule Sales Market Share by Country (2021-2032) Figure 49. Brazil Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South Africa Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Saudi Arabia Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Turkey Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Argentina Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 54. UAE Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Egypt Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Chile Non-animal Capsule Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Global Non-animal Capsule Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Non-animal Capsule Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Non-animal Capsule Revenue (2021-2032) & (US$ Million) Figure 60. North America Non-animal Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Non-animal Capsule Revenue (2021-2032) & (US$ Million) Figure 62. Europe Non-animal Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Non-animal Capsule Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Non-animal Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Non-animal Capsule Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Non-animal Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Non-animal Capsule Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Non-animal Capsule Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • HPMC
  • Starch
  • Plant Polysaccharides
  • Others
Applications
  • Pharmaceutical
  • Health Supplements
  • Others
Companies covered
  • Qingdao Capsule
  • Lonza (Capsugel)
  • Shanxi GS Capsule
  • Sunil Healthcare
  • Suheung Capsule
  • SIRIO
  • Robinson Pharma
  • Qualicaps
  • Procaps Laboratorios
  • Lefan Capsule
  • Eurocaps
  • Er-kang
  • Catalent
  • Captek
  • CapsCanada
  • Best Formulations
  • Bahrain Pharma
  • Aenova
  • ACG Associated Capsules

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-animal Capsule Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-animal Capsule Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non-animal Capsule Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non-animal Capsule Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non-animal Capsule Market Dynamics
  1. 2.1 Non-animal Capsule Industry Trends
  2. 2.2 Non-animal Capsule Industry Drivers
  3. 2.3 Non-animal Capsule Industry Opportunities and Challenges
  4. 2.4 Non-animal Capsule Industry Restraints
3 Non-animal Capsule Market by Manufacturers
  1. 3.1 Global Non-animal Capsule Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non-animal Capsule Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non-animal Capsule Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non-animal Capsule Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-animal Capsule Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non-animal Capsule Manufacturers, Product Type & Application
  7. 3.7 Global Non-animal Capsule Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-animal Capsule Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-animal Capsule Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-animal Capsule Tier 1, Tier 2, and Tier 3
4 Non-animal Capsule Market by Type
  1. 4.1 Non-animal Capsule Type Introduction
  2. 4.1.1 HPMC
  3. 4.1.2 Starch
  4. 4.1.3 Plant Polysaccharides
  5. 4.1.4 Others
  6. 4.2 Global Non-animal Capsule Sales by Type
  7. 4.2.1 Global Non-animal Capsule Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Non-animal Capsule Sales by Type (2021-2032)
  9. 4.2.3 Global Non-animal Capsule Sales Market Share by Type (2021-2032)
  10. 4.3 Global Non-animal Capsule Revenue by Type
  11. 4.3.1 Global Non-animal Capsule Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Non-animal Capsule Revenue by Type (2021-2032)
  13. 4.3.3 Global Non-animal Capsule Revenue Market Share by Type (2021-2032)
5 Non-animal Capsule Market by Application
  1. 5.1 Non-animal Capsule Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Health Supplements
  4. 5.1.3 Others
  5. 5.2 Global Non-animal Capsule Sales by Application
  6. 5.2.1 Global Non-animal Capsule Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-animal Capsule Sales by Application (2021-2032)
  8. 5.2.3 Global Non-animal Capsule Sales Market Share by Application (2021-2032)
  9. 5.3 Global Non-animal Capsule Revenue by Application
  10. 5.3.1 Global Non-animal Capsule Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Non-animal Capsule Revenue by Application (2021-2032)
  12. 5.3.3 Global Non-animal Capsule Revenue Market Share by Application (2021-2032)
6 Global Non-animal Capsule Sales by Region
  1. 6.1 Global Non-animal Capsule Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-animal Capsule Sales by Region (2021-2032)
  3. 6.2.1 Global Non-animal Capsule Sales by Region (2021-2026)
  4. 6.2.2 Global Non-animal Capsule Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-animal Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non-animal Capsule Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non-animal Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non-animal Capsule Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non-animal Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non-animal Capsule Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non-animal Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non-animal Capsule Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non-animal Capsule Revenue by Region
  1. 7.1 Global Non-animal Capsule Revenue by Region
  2. 7.1.1 Global Non-animal Capsule Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non-animal Capsule Revenue by Region (2021-2026)
  4. 7.1.3 Global Non-animal Capsule Revenue by Region (2027-2032)
  5. 7.1.4 Global Non-animal Capsule Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non-animal Capsule Revenue (2021-2032)
  8. 7.2.2 North America Non-animal Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non-animal Capsule Revenue (2021-2032)
  11. 7.3.2 Europe Non-animal Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non-animal Capsule Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non-animal Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non-animal Capsule Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non-animal Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Qingdao Capsule
  2. 8.1.1 Qingdao Capsule Company Information
  3. 8.1.2 Qingdao Capsule Business Overview
  4. 8.1.3 Qingdao Capsule Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Qingdao Capsule Non-animal Capsule Product Portfolio
  6. 8.1.5 Qingdao Capsule Recent Developments
  7. 8.2 Lonza (Capsugel)
  8. 8.2.1 Lonza (Capsugel) Company Information
  9. 8.2.2 Lonza (Capsugel) Business Overview
  10. 8.2.3 Lonza (Capsugel) Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lonza (Capsugel) Non-animal Capsule Product Portfolio
  12. 8.2.5 Lonza (Capsugel) Recent Developments
  13. 8.3 Shanxi GS Capsule
  14. 8.3.1 Shanxi GS Capsule Company Information
  15. 8.3.2 Shanxi GS Capsule Business Overview
  16. 8.3.3 Shanxi GS Capsule Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanxi GS Capsule Non-animal Capsule Product Portfolio
  18. 8.3.5 Shanxi GS Capsule Recent Developments
  19. 8.4 Sunil Healthcare
  20. 8.4.1 Sunil Healthcare Company Information
  21. 8.4.2 Sunil Healthcare Business Overview
  22. 8.4.3 Sunil Healthcare Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sunil Healthcare Non-animal Capsule Product Portfolio
  24. 8.4.5 Sunil Healthcare Recent Developments
  25. 8.5 Suheung Capsule
  26. 8.5.1 Suheung Capsule Company Information
  27. 8.5.2 Suheung Capsule Business Overview
  28. 8.5.3 Suheung Capsule Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Suheung Capsule Non-animal Capsule Product Portfolio
  30. 8.5.5 Suheung Capsule Recent Developments
  31. 8.6 SIRIO
  32. 8.6.1 SIRIO Company Information
  33. 8.6.2 SIRIO Business Overview
  34. 8.6.3 SIRIO Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SIRIO Non-animal Capsule Product Portfolio
  36. 8.6.5 SIRIO Recent Developments
  37. 8.7 Robinson Pharma
  38. 8.7.1 Robinson Pharma Company Information
  39. 8.7.2 Robinson Pharma Business Overview
  40. 8.7.3 Robinson Pharma Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Robinson Pharma Non-animal Capsule Product Portfolio
  42. 8.7.5 Robinson Pharma Recent Developments
  43. 8.8 Qualicaps
  44. 8.8.1 Qualicaps Company Information
  45. 8.8.2 Qualicaps Business Overview
  46. 8.8.3 Qualicaps Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Qualicaps Non-animal Capsule Product Portfolio
  48. 8.8.5 Qualicaps Recent Developments
  49. 8.9 Procaps Laboratorios
  50. 8.9.1 Procaps Laboratorios Company Information
  51. 8.9.2 Procaps Laboratorios Business Overview
  52. 8.9.3 Procaps Laboratorios Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Procaps Laboratorios Non-animal Capsule Product Portfolio
  54. 8.9.5 Procaps Laboratorios Recent Developments
  55. 8.10 Lefan Capsule
  56. 8.10.1 Lefan Capsule Company Information
  57. 8.10.2 Lefan Capsule Business Overview
  58. 8.10.3 Lefan Capsule Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lefan Capsule Non-animal Capsule Product Portfolio
  60. 8.10.5 Lefan Capsule Recent Developments
  61. 8.11 Eurocaps
  62. 8.11.1 Eurocaps Company Information
  63. 8.11.2 Eurocaps Business Overview
  64. 8.11.3 Eurocaps Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Eurocaps Non-animal Capsule Product Portfolio
  66. 8.11.5 Eurocaps Recent Developments
  67. 8.12 Er-kang
  68. 8.12.1 Er-kang Company Information
  69. 8.12.2 Er-kang Business Overview
  70. 8.12.3 Er-kang Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Er-kang Non-animal Capsule Product Portfolio
  72. 8.12.5 Er-kang Recent Developments
  73. 8.13 Catalent
  74. 8.13.1 Catalent Company Information
  75. 8.13.2 Catalent Business Overview
  76. 8.13.3 Catalent Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Catalent Non-animal Capsule Product Portfolio
  78. 8.13.5 Catalent Recent Developments
  79. 8.14 Captek
  80. 8.14.1 Captek Company Information
  81. 8.14.2 Captek Business Overview
  82. 8.14.3 Captek Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Captek Non-animal Capsule Product Portfolio
  84. 8.14.5 Captek Recent Developments
  85. 8.15 CapsCanada
  86. 8.15.1 CapsCanada Company Information
  87. 8.15.2 CapsCanada Business Overview
  88. 8.15.3 CapsCanada Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CapsCanada Non-animal Capsule Product Portfolio
  90. 8.15.5 CapsCanada Recent Developments
  91. 8.16 Best Formulations
  92. 8.16.1 Best Formulations Company Information
  93. 8.16.2 Best Formulations Business Overview
  94. 8.16.3 Best Formulations Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Best Formulations Non-animal Capsule Product Portfolio
  96. 8.16.5 Best Formulations Recent Developments
  97. 8.17 Bahrain Pharma
  98. 8.17.1 Bahrain Pharma Company Information
  99. 8.17.2 Bahrain Pharma Business Overview
  100. 8.17.3 Bahrain Pharma Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bahrain Pharma Non-animal Capsule Product Portfolio
  102. 8.17.5 Bahrain Pharma Recent Developments
  103. 8.18 Aenova
  104. 8.18.1 Aenova Company Information
  105. 8.18.2 Aenova Business Overview
  106. 8.18.3 Aenova Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Aenova Non-animal Capsule Product Portfolio
  108. 8.18.5 Aenova Recent Developments
  109. 8.19 ACG Associated Capsules
  110. 8.19.1 ACG Associated Capsules Company Information
  111. 8.19.2 ACG Associated Capsules Business Overview
  112. 8.19.3 ACG Associated Capsules Non-animal Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 ACG Associated Capsules Non-animal Capsule Product Portfolio
  114. 8.19.5 ACG Associated Capsules Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-animal Capsule Value Chain Analysis
  2. 9.1.1 Non-animal Capsule Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-animal Capsule Production Mode & Process
  6. 9.2 Non-animal Capsule Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-animal Capsule Distributors
  9. 9.2.3 Non-animal Capsule Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst